© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
The AJMC® Lupus compendium is a comprehensive resource for clinical news and expert insights for the inflammatory disease that occurs when the immune system attacks its own tissues.
September 25th 2022, 5:05pm
The patient was successfully treated with rituximab and intravenous immunoglobulin.
September 19th 2022, 1:50pm
The case involved a 69-year-old man who presented with lupus nephritis.
September 15th 2022, 11:30am
A new review article explains the role of biologics in treatment systemic lupus erythematosus (SLE) and lupus nephritis.
September 13th 2022, 11:09am
New data show litifilimab outperformed placebo in patients with active arthritis and skin manifestations due to systemic lupus erythematosus (SLE).
September 7th 2022, 8:13pm
The authors found the association by comparing echocardiographic and biochemical changes after 5 years in patients with systemic lupus erythematosus (SLE).
September 6th 2022, 1:58pm
A new study finds anxiety and depression are more common in people with systemic lupus erythematosus (SLE) if they also have nephritis.
August 31st 2022, 12:33pm
The findings mean it may be feasible to use adult systemic lupus nephritis (SLE) trial data to reduce the data needed for pediatric indications.
August 26th 2022, 11:11am
The use of existing guidelines for pediatric treatment varies significantly among sites, a new study has found.
August 22nd 2022, 11:30pm
A new review outlines what is known about cardiovascular disease (CVD) risk in patients with systemic lupus erythematosus (SLE) and how that might affect patient care.
August 17th 2022, 6:15pm
A new case report highlights the potential benefits of risk assessment for women with a family history of autoimmune diseases, such as systemic lupus erythematosus (SLE), who are considering the human papillomavirus (HPV) vaccine.